Allurion Technologies Announces 1-for-25 Reverse Stock Split Effective January 3
Allurion Technologies Announces 1-for-25 Reverse Stock Split Effective January 3
Allurion Technologies, Inc. (NYSE:ALUR) ("Allurion" or the "Company"), a company dedicated to ending obesity, today announced that its Board of Directors has determined to effect a one-for-twenty five reverse stock split of the Company's common stock, par value $0.0001 per share (the "Common Stock").
Allurion Technologies, Inc. (紐交所:ALUR)（"Allurion"或"公司"）是一家致力於終結肥胖的公司，今天宣佈其董事會已決定對公司普通股進行1比25的反向拆股，每股面值爲$0.0001（即"普通股"）。
The reverse stock split will take effect at 12:01 a.m. Eastern Time on January 3, 2025, and the Company's Common Stock will begin trading on a split-adjusted basis on The New York Stock Exchange ("NYSE") as of the opening of trading on January 3, 2025. The CUSIP number of 02008G 201 will be assigned to the Company's Common Stock when the reverse stock split becomes effective.
反向拆股將於2025年1月3日東部時間凌晨12:01生效，公司普通股將在2025年1月3日開盤時在紐約證券交易所（"紐交所"）開始以拆股調整後的基礎進行交易。當反向拆股生效時，公司普通股將分配CUSIP編號02008G 201。
When the reverse stock split becomes effective, every twenty five (25) of the Company's issued shares of Common Stock will be combined into one (1) issued share of Common Stock, without any change to the par value per share. This will reduce the number of outstanding shares of Common Stock from approximately 67,781,585 million shares to approximately 2,711,263 million shares.
當反向拆股生效時，公司已發行的每25股普通股將合併爲1股普通股，面值不變。這將使流通的普通股從大約6778158500萬股減少到大約271126300萬股。
